Large-scale sequencing projects have revealed several potential AML driver genes, including NPM1, CEBPA, DNMT3A, TET2, RUNX1, ASXL1, IDH2, and MLL, and have identified critical mutations in FLT3, IDH1, KIT, and RAS. Here, KMT2A is linked to acute myeloid leukemia.